In this first-ever proof-of-concept study for the therapeutic potential of human iPSC-derived cells in a pulmonary disease,  Christine Happle and colleagues use Chipcytometry to analyse the successful transplantation of these cells in a humanized mouse model of hereditary pulmonary alveolar proteinosis (herPAP).

Contact Us

Please tell us how we can help you.

Nicht lesbar? Text ändern. captcha txt

Beginnen Sie mit der Eingabe und drücken Sie Enter, um zu suchen